University of Missouri
Columbia, Missouri, 65212, United States
NCT Number: NCT03203694
The purpose of the present study is to determine the effects of increased walking and lower body heating on leg vascular function in patients with type 2 diabetes (T2D).
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Columbia, Missouri, 65212, United States
The notion that habitual aerobic exercise increases insulin-induced vasodilation is largely founded on rodent studies, hence the urgent need for human studies, especially in patients with type 2 diabetes (T2D). For example, it remains unknown if increased walking, the most common form of physical activity, enhances skeletal muscle vasodilator actions of insulin in T2D. In addition, the molecular mechanisms by which exercise improves vasoreactivity to insulin have not been examined in humans. The investigators propose that in T2D patients who are sedentary (i.e., the vast majority), increased leg blood flow with walking or local heating signifies a vital strategy to correct vascular insulin resistance. This study will establish whether increased physical activity and associated hemodynamic forces (e.g., shear stress) are a direct form of vascular medicine in humans.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with type 2 diabetes who are overweight and obese (BMI 25-50 kg/m2), 35 to 65 years of age, and sedentary (<60 minutes structured exercise/week). Healthy volunteers without type 2 diabetes: 18 to 65 years of age.
Exclusion criteria
The walking program will consist of 45 minutes of walking (at a moderate pace) 5 days per week for 8 weeks.
Subjects will be instructed to continue their usual lifestyle for 8 weeks.
Subjects will be studied at one time only.
This intervention consists of 60 minutes of lower body heating (40-42 degree C).
This intervention consists of 60 minutes of lower body heating (40-42 degree C) 7 days per week for 7 days.
Subjects will be studied at one time only.
Time frame: Percent change from baseline leg blood flow during 60 minutes of insulin stimulation.
Measure of blood flow in response to insulin. Blood flow is measured via Doppler ultrasound at the femoral artery. Measurements are performed at baseline (t0) and after 60 minutes of insulin stimulation (t60).
Time frame: Change from baseline insulin-stimulated leg blood flow following 1 heating session, 7 days of heating intervention, or 8 weeks of walking intervention/no intervention.
Measure of blood flow in response to insulin. Blood flow is measured via Doppler ultrasound at the femoral artery. Measurements are performed pre-intervention and post-intervention at baseline (t0) and after 60 minutes of insulin stimulation (t60). Outcome measure indicates whether percent change in insulin-stimulated blood flow increased or decreased following intervention. Interventions that show an increase demonstrate an improvement in insulin-stimulated blood flow.
University of Missouri-Columbia
Other
Restoring Vasodilator Actions of Insulin in Patients With Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07619495
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT02328599
Body Weight, Diabetes Mellitus
Boston, Massachusetts, United States
View Trial DetailsNCT05110846
Body Weight, Diabetes Mellitus
Guadalajara, Jalisco, Mexico
View Trial DetailsNCT05394519
Body Weight, Diabetes Mellitus
Concord, California, United States
View Trial Details